Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Bladder cancer detection in urine by novel methylation markers

20 Nov 2024

Abstract excerpt

Although cystoscopy is a reliable tool for detecting bladder cancer (BC) in patients with hematuria, it is invasive, costly and often unnecessary since most patients with hematuria do not have BC. Consequently, developing urinary biomarkers for non-invasive BC detection is a major clinical need. While DNA methylation markers hold promise, diagnostic performance can still be improved. We assessed 11 candidate...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bladder and Urothelial Cancer Treatments
Share to Epigenetics and DNA Methylation
Share to Urinary and Genital Oncology Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39567591
DOI: 10.1038/s41598-024-77781-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Bladder cancer detection in urine by novel methylation markersPMID 39567591Read ↗

Urine DNA methylation assay enables early detection and recurrence monitoring for bladder cancerSemantic proximity Read ↗

EarlyTect BCD, a Streamlined PENK Methylation Test in Urine DNA, Effectively Detects Bladder Cancer in Patients with HematuriaSemantic proximity Read ↗

BladMetrix: a novel urine DNA methylation test with high accuracy for detection of bladder cancer in hematuria patientsSemantic proximity Read ↗

Urinary Biomarkers in Bladder Cancer: FDA-Approved Tests and Emerging Tools for Diagnosis and SurveillanceSemantic proximity Read ↗

Urine cell-based DNA methylation classifier for monitoring bladder cancerSemantic proximity Read ↗

Roles for epigenetic and other biomarkers in upper tract urothelial carcinoma diagnosis and surveillanceSemantic proximity Read ↗

UroMark—a urinary biomarker assay for the detection of bladder cancerSemantic proximity Read ↗

A Two-Gene Methylation Signature for the Diagnosis of Bladder Cancer in UrineSemantic proximity Read ↗

A urinary assay for mutation and methylation biomarkers in the diagnosis and recurrence prediction of non-muscle invasive bladder cancer patients.Semantic proximity Read ↗

Hypermethylation Loci of ZNF671, IRF8, and OTX1 as Potential Urine-Based Predictive Biomarkers for Bladder CancerSemantic proximity Read ↗

Biomarkers of Bladder Cancer: Cell-Free DNA, Epigenetic Modifications and Non-Coding RNAsSemantic proximity Read ↗

Bladder cancer detection in urine using DNA methylation markers: a technical and prospective preclinical validationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.